The coronavirus pandemic has affected everyone — but not equally, with low-wage workers and communities of color especially hard hit.
Only about 6 percent of medical practitioners have obtained a government waiver that allows them to prescribe a crucial drug for treating opioid addiction. Here's why that's a problem.
“What is unique at this time is that the difference between what the private sector is paying and what the public sector is paying for health care is starting to diverge,” says John Hopkins' Gerard Anderson.
Diabetes among African-American adults has reached epidemic proportions. Healthy Bodies, Healthy Souls -- an innovative public health program in Baltimore -- is going after the problem by connecting with people where they pray.
West Virginia occupies a top slot on almost every awful health ranking: diabetes, heart disease, stroke, kidney disease and others.
Jody Ranck is an independent consultant and principal investigator at the Public Health Institute in Oakland, where he is helping create a new Public Health Innovation Center that will develop social media, mobile tools, and social innovation strategies to rethink public health practice. He is also a consultant with the UN Economic Commission for Africa and Stanford University School of Medicine, where he assists in creating new global health innovation and design programs.
Part 1: Innovative ways are sought to get patients to follow their treatment
Winnie O. Willis is a California Endowment board member and professor emeritus of public health at SDSU's Graduate School of Public Health, with a specialization in maternal and child health services, development and evaluation. From 1994 to 2000, she was director of SDSU's Institute for Public Health, an organization working to bridge the gap between academics and practice in the public health arena. Prior to joining the GSPH faculty in 1984, she was an assistant professor of maternal and child health at the University of Michigan School of Public Health.
Robert A. Montgomery, MD, DPhil, is an Associate Professor of Surgery, Director of the Incompatible Kidney Transplant Program, Chief of the Division of Transplantation, and Director of the Comprehensive Transplant Center, at the Johns Hopkins University and Hospital. He received his Medical education at the University of Rochester where he was the valedictorian of his class. He received his PhD at the University of Oxford, England in molecular immunology. Montgomery completed his general surgical and multi-organ transplantation training at Johns Hopkins Hospital.
Dr. Randall Stafford is an associate professor of medicine at the Stanford Prevention Research Center and a fellow at CHP/PCOR. He is an epidemiologist, health services researcher and primary-care internist. His research focuses on improving chronic disease prevention, and exploring the mechanisms by which physicians adopt new prevention practices.